At the time of writing, Arcadia Biosciences Inc [RKDA] stock is trading at $5.45, up 102.08%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RKDA shares have gain 97.46% over the last week, with a monthly amount glided 44.95%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Arcadia Biosciences Inc [NASDAQ: RKDA] stock has seen the most recent analyst activity on August 17, 2020, when H.C. Wainwright reiterated its Buy rating and also revised its price target to $12 from $14. Previously, Piper Jaffray downgraded its rating to Neutral on May 12, 2017. On June 09, 2015, Piper Jaffray initiated with a Overweight rating and assigned a price target of $10 on the stock. Credit Suisse started tracking the stock assigning a Outperform rating and suggested a price target of $14 on June 09, 2015.
For the past year, the stock price of Arcadia Biosciences Inc fluctuated between $1.85 and $5.34. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Arcadia Biosciences Inc [NASDAQ: RKDA] shares were valued at $5.45 at the most recent close of the market. An investor can expect a potential return of 10.09% based on the average RKDA price forecast.
Analyzing the RKDA fundamentals
According to Arcadia Biosciences Inc [NASDAQ:RKDA], the company’s sales were 5.27M for trailing twelve months, which represents an -3.76% plunge. Gross Profit Margin for this corporation currently stands at 0.4% with Operating Profit Margin at -1.15%, Pretax Profit Margin comes in at -0.83%, and Net Profit Margin reading is -1.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.51 and Total Capital is -0.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.56 points at the first support level, and at 1.68 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.82, and for the 2nd resistance point, it is at 12.20.
Ratios To Look Out For
It is important to note that Arcadia Biosciences Inc [NASDAQ:RKDA] has a current ratio of 4.60. As well, the Quick Ratio is 4.24, while the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 1.41, the price to book ratio is 0.72.
Transactions by insiders
Recent insider trading involved Kawakami Mark, Chief Financial Officer, that happened on Aug 01 ’24 when 700.0 shares were purchased. Chief Executive Officer, Schaefer Thomas J. completed a deal on Aug 01 ’24 to buy 700.0 shares. Meanwhile, Chief Financial Officer Schaefer Thomas J. bought 700.0 shares on Feb 01 ’24.
